Panther Fusion® Assays

Growth through menu expansion and consolidation


The expanding menu of Panther Fusion® assays on the Panther Fusion® system continue the legacy of testing precision and total lab automation that first began with the fully automated Panther® system. The expanded diagnostic menu and ability to consolidate testing aid healthcare providers in diagnoses and maximizing potential in the laboratory.

Panther Fusion® System


The Panther Fusion system offers flexibility, capacity and expanded menu plus the ability to run laboratory developed tests. Add on the power to run real-time PCR, TMA and RT-TMA assays on a single, fully automated platform. With the Panther Fusion® module you can consolidate testing, increase walkaway-time and enhance flexibility.

Learn More

Consolidate your assay menu


The Aptima® and Panther Fusion assays help guide patient care and enable early detection. With a menu and pipeline of world-class assays you can consolidate your molecular testing today and meet your lab’s growing needs tomorrow.

Learn More

The Panther Fusion® Respiratory assays


The Panther Fusion Respiratory assays for syndromic respiratory testing are the premier set of assays on the Panther Fusion system. You now can provide truly personalized syndromic respiratory testing with qualitative detection and differentiation of the most common respiratory viruses using a single patient sample. Each Panther Fusion Respiratory assay can be processed independently or simultaneously with other Panther Fusion and Aptima assays.

Learn More

Panther Fusion® GBS assay


The Panther Fusion GBS assay further expands the molecular testing menu on the Panther Fusion system. This assay detects the gram-positive bacterium Streptococcus agalactiae (GBS) in pregnant women so providers can prevent its transmission to their babies.1 GBS has serious long-term health consequences, including death, in newborns.

Learn More


* The Panther Fusion SARS-CoV-2 assay has not been FDA cleared or approved: This test has been authorized by FDA under an EUA for use by authorized laboratories; The Panther Fusion SARS-CoV-2 assay has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The Panther Fusion SARS-CoV-2 assay is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
Reference: 1. Panther Fusion GBS assay. US package insert AW-17997. Hologic, Inc.; 2018.

Growth through menu expansion and consolidation


The expanding menu of Panther Fusion® assays on the Panther Fusion® system continue the legacy of testing precision and total lab automation that first began with the fully automated Panther® system. The expanded diagnostic menu and ability to consolidate testing aid healthcare providers in diagnoses and maximizing potential in the laboratory.

Panther Fusion® System


The Panther Fusion system offers flexibility, capacity and expanded menu plus the ability to run laboratory developed tests. Add on the power to run real-time PCR, TMA and RT-TMA assays on a single, fully automated platform. With the Panther Fusion® module you can consolidate testing, increase walkaway-time and enhance flexibility.

Learn More

Consolidate your assay menu


The Aptima® and Panther Fusion assays help guide patient care and enable early detection. With a menu and pipeline of world-class assays you can consolidate your molecular testing today and meet your lab’s growing needs tomorrow.

Learn More

The Panther Fusion® Respiratory assays


The Panther Fusion Respiratory assays for syndromic respiratory testing are the premier set of assays on the Panther Fusion system. You now can provide truly personalized syndromic respiratory testing with qualitative detection and differentiation of the most common respiratory viruses using a single patient sample. Each Panther Fusion Respiratory assay can be processed independently or simultaneously with other Panther Fusion and Aptima assays.

Learn More
 

The Panther Fusion® MRSA assay


The Panther Fusion MRSA assay is designed for the qualitative detection and differentiation of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) DNA from nasal swabs in patients at risk for nasal colonization. It is intended to aid in the prevention and control of SA and MRSA infections in healthcare settings.

Learn More
 

Panther Fusion® GBS assay


The Panther Fusion GBS assay further expands the molecular testing menu on the Panther Fusion system. This assay detects the gram-positive bacterium Streptococcus agalactiae (GBS) in pregnant women so providers can prevent its transmission to their babies.1 GBS has serious long-term health consequences, including death, in newborns.

Learn More


* The Panther Fusion SARS-CoV-2 assay has not been FDA cleared or approved: This test has been authorized by FDA under an EUA for use by authorized laboratories; The Panther Fusion SARS-CoV-2 assay has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The Panther Fusion SARS-CoV-2 assay is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
Reference: 1. Panther Fusion GBS assay. OUS package insert AW-17997. Hologic, Inc.; 2018.
Want Image Slider on Tab Click
no